INDIA: LATEST INTERVIEWS MORE INTERVIEWS

"After the pandemic, India has become one of the most recognized medical suppliers to the world as the country has shown that it can supply to ever increasing demands."
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
"ZIM sees great opportunity in improving the functioning of the overall healthcare system through providing more patient centric drug delivery systems."

INDIA: LATEST ARTICLES

India’s API Industry: Exporting to the World

March 17, 2020
From being a net importer of APIs, India is now a world-leading exporter.

The World’s Pharmacy: India’s Generic Drug Industry

February 12, 2020
India must adapt to maintain its position as the world’s largest supplier of generic drugs.

The 2020s: India’s decade?

November 19, 2019
As 2020 approaches, GBR takes a look at how far India has come to achieving its Pharma Vision 2020

INDIA: RECENTLY RELEASED PUBLICATIONS

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Western USA Mining 2024

GBR's Western USA Mining 2024 report offers a comprehensive overview of the current state of the mining industry and what Washington and all stakeholders across the mining value chain are doing to achieve mineral independence.

PARTNER EVENTS